Patent details

Basic Information

Publication number:

EP1143989

PCT Application Number:

PCT/US/2000/000942

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP009024159

PCT Publication Number:

WO/2000/041548

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

EXENDINS FOR GLUCAGON SUPPRESSION

French Title of Invention:

EXENDINES DESTINES A LA SUPPRESSION DU GLUCAGON

German Title of Invention:

EXENDINE ZUR GLUCAGON SUPPRESSION

SPC Number:

Dates

Filing date:

14/01/2000

Grant date:

13/12/2006

EP Publication Date:

13/12/2006

PCT Publication Date:

20/07/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/10/2001

EP B1 Publication Date:

13/12/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

14/01/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/02/2013

 

 

Name:

AMYLIN PHARMACEUTICALS, LLC

Address:

TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, United States (US)

Name:

ASTRAZENECA PHARMACEUTICALS , LP

Address:

CONCORD PIKE 1800, WILMINGTON, DELAWARE, United States (US)

History of Owners

From:

14/01/2000

To:

03/02/2013

Name:

AMYLIN PHARMACEUTICALS INC.

Address:

9373 Towne Centre Drive, Suite 250, San Diego California 92121, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

13/12/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

GEDULIN Bronislava

Address:

United States (US)

2

Name:

YOUNG Andrew

Address:

United States (US)

Priority

1

Priority Number:

116380 P

Priority Date:

14/01/1999

Priority Country:

United States (US)

2

Priority Number:

132017 P

Priority Date:

30/04/1999

Priority Country:

United States (US)

3

Priority Number:

175365 P

Priority Date:

10/01/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/17;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/12/2018

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages